PreveCeutical Medical Inc.
PRVCF
$0.02
$0.002.37%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -623.00K | -907.00K | -532.10K | -172.60K | -246.20K |
| Total Depreciation and Amortization | 2.60K | 2.90K | 2.20K | 1.80K | 1.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.80K | 439.60K | 147.70K | 106.90K | 63.80K |
| Change in Net Operating Assets | 154.70K | 59.20K | 309.50K | 16.70K | 98.60K |
| Cash from Operations | -377.90K | -405.20K | -72.70K | -47.10K | -81.90K |
| Capital Expenditure | 0.00 | -2.10K | -- | -500.00 | -100.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.60K | 300.00 | -40.00K | -- | -- |
| Cash from Investing | 39.60K | -1.80K | -40.00K | -500.00 | -100.00 |
| Total Debt Issued | -- | -58.90K | 58.90K | 83.20K | 22.80K |
| Total Debt Repaid | -30.70K | -67.30K | -- | -1.50K | -1.00K |
| Issuance of Common Stock | 622.90K | 688.50K | 50.00K | 43.90K | 90.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 430.00K | 406.40K | 75.90K | 89.70K | 82.00K |
| Foreign Exchange rate Adjustments | -19.50K | -200.00 | -500.00 | -100.00 | 100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.20K | -900.00 | -37.40K | 42.10K | 0.00 |